• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INOGEN MINI ICD DR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INOGEN MINI ICD DR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT) Back to Search Results
Model Number D013
Medical Device Problem Codes Premature Discharge of Battery (1057); Inappropriate/Inadequate Shock/Stimulation (1574)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 08/29/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event or Problem Description
Boston scientific received information that this implantable cardioverter defibrillator's (icd) battery rapidly depleted.This device was explanted.No additional adverse patient effects were reported.
 
Additional Manufacturer Narrative
Upon receipt at our quality assurance laboratory, the device was thoroughly inspected and analyzed.External visual inspection identified minor scratches on the case and header that likely occurred during explant.Review of device memory confirmed that the device had reached elective replacement indicator (eri) status due to long charge times.The case was opened and the device was attached to an external coil, the charging frequency was measured and determined at half of the normal frequency.This indicates that the diode component connection is open.This incomplete electrical pathway within the devices shock charging circuitry resulted in the lengthened charge times that triggered eri.Despite exhibiting extended charge times, the maximum shock energy was still available and therapy availability is not compromised in devices exhibiting this issue.Therapy would have been available to the patient if required, albeit with a somewhat longer charge time.This intermittent connection manifests during capacitor reformations or therapy charges, and was confirmed as the root cause for the device triggering eri.
 
Event or Problem Description
Supplemental report is being submitted with analysis results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INOGEN MINI ICD DR
Common Device Name
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key8053884
Report Number2124215-2018-61620
Device Sequence Number11289165
Product Code LWS
UDI-Device Identifier00802526533846
UDI-Public00802526533846
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P960040/S306
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Device Explanted Year2018
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date04/16/2016
Device Model NumberD013
Device Catalogue NumberD013
Device Lot Number101097
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/16/2018
Initial Date Received by Manufacturer 09/29/2018
Supplement Date Received by Manufacturer11/15/2018
Initial Report FDA Received Date11/08/2018
Supplement Report FDA Received Date12/07/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Life Threatening; Required Intervention;
Patient Age15 YR
-
-